Alvara Therapeutics develops small-molecule therapies for chronic kidney disease.
Alvara Therapeutics has raised $646K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2026.
Alvara Therapeutics's investors include BioInnovation Institute Venture Lab.
Alvara Therapeutics is headquartered in Copenhagen, Denmark.
Alvara Therapeutics develops small-molecule therapies for chronic kidney disease.
Alvara Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alvara Therapeutics — Funding & Investors." VCBacked, September 16, 2026, https://www.vcbacked.co/company/alvara-therapeutics. Accessed October 1, 2026.
VCBacked. (2026). Alvara Therapeutics — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/alvara-therapeutics
{{cite web |title=Alvara Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alvara-therapeutics |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated